Grantham, Mayo, Van Otterloo & Co (GMO)’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Other funds holding HRMY
Grantham, Mayo, Van Otterloo & Co (GMO)'s HRMY Position: Q3 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) increased its Harmony Biosciences (HRMY) stake by 19% in Q3 2026, buying an estimated $80.3K and bringing the position to 12,970 shares worth $509K. The position accounts for ﹤0.01% of the portfolio, ranked #597.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in HRMY in Q4 2025 and has held it in 4 quarters since. 358 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 12,970 shares of Harmony Biosciences worth $509K as of Q3 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) bought 2,079 Harmony Biosciences shares in Q3 2026, an estimated $80.3K.
- Harmony Biosciences made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q3 2026, its #597 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Harmony Biosciences in Q4 2025 and has held it in 4 quarters since.
- 358 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2026, filed 13 Nov 2026.